Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00979732 · ClinicalTrials.gov registry record · NA
The Effect of Grape Seed Extract on Blood Pressure in People With Pre-Hypertension
A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT00979732 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 33 participants.
The verdict
NCT00979732, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
In this research study, the investigators are interested in learning how extracts from grape seeds can help those individuals with high blood pressure. The investigators also hope to learn how grape seed extract effects your blood and cell functions. The grape seed extract the investigators will use in the study will be provided either in a beverage or a capsule form and is currently available on the market. This study is also using a placebo; therefore the treatment subjects receive may or may not contain the grape seed extract. The purpose of this study is to determine if the grape seed extract (GSE) will lower blood pressure in people with slightly high blood pressure (Pre-Hypertension).
Interventions
- DIETARY_SUPPLEMENT grape seed extract
- DIETARY_SUPPLEMENT grape seed extract placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2009-11-15 |
| Est. Completion | 2014-10-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00979732
The ClinicalTrials.gov registry entry for NCT00979732 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which grape seed extract is the first listed.
NCT00979732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00979732 about?
NCT00979732 is a clinical study titled "The Effect of Grape Seed Extract on Blood Pressure in People With Pre-Hypertension". In this research study, the investigators are interested in learning how extracts from grape seeds can help those individuals with high blood pressure. The investigators also hope to learn how grape seed extract effects your blood and cell functions. The grape seed extract the investigators will us...
What is the current status of trial NCT00979732?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2009-11-15. Estimated completion is 2014-10-15.
What interventions are being tested in trial NCT00979732?
The interventions under investigation include: grape seed extract (DIETARY_SUPPLEMENT), grape seed extract placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00979732?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.